Literature DB >> 17846743

Vibrotactile threshold measurement for detecting peripheral neuropathy: defining variability and a normal range for clinical and research use.

J Duke1, M McEvoy, D Sibbritt, M Guest, W Smith, J Attia.   

Abstract

AIMS/HYPOTHESIS: We aimed to define normal ranges for vibration sense as measured by vibratory perception thresholds (VPTs) using biothesiometry.
METHODS: We performed biothesiometry in a community-dwelling sample of 901 people aged 55 to 85 years who did not have diabetes. We quantitated the variation between repeat measures using analysis of variance and Bland-Altman plots. We also plotted the age- and sex-specific reference ranges.
RESULTS: We found small but statistically significant differences between repeat measures using the ascending and descending method of limits. Statistically higher vibration thresholds were noted on the right arm and leg compared with the left. Significantly higher vibration thresholds were also seen in men vs women for both lower limbs. We also defined sex-specific reference intervals (normal ranges) for biothesiometry for older persons and quantitated the increase in vibration threshold with increasing age. CONCLUSIONS/
INTERPRETATION: For reliability, it may be sufficient to obtain the average of two ascending measures separated by at least 1 min in just the right hand or right foot, since this is usually the one with the higher threshold. Although identical reference ranges can be used for men and women for the upper limb, there are significant differences in the lower limbs. The major determinant of VPT is age: we have established age-specific norms for VPT testing for adults between 55 and 85 years of age.

Entities:  

Mesh:

Year:  2007        PMID: 17846743     DOI: 10.1007/s00125-007-0813-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Normative vibrotactile thresholds measured at five European test centres.

Authors:  Christopher J Lindsell; Michael J Griffin
Journal:  Int Arch Occup Environ Health       Date:  2003-06-25       Impact factor: 3.015

3.  Assessment of memory complaint in age-associated memory impairment: the MAC-Q.

Authors:  T H Crook; E P Feher; G J Larrabee
Journal:  Int Psychogeriatr       Date:  1992       Impact factor: 3.878

4.  Vibration sensitivity thresholds: methodological considerations.

Authors:  O Aaserud; J Juntunen; E Matikainen
Journal:  Acta Neurol Scand       Date:  1990-10       Impact factor: 3.209

5.  Normal distributions of thermal and vibration sensory thresholds.

Authors:  G Bartlett; J D Stewart; R Tamblyn; M Abrahamowicz
Journal:  Muscle Nerve       Date:  1998-03       Impact factor: 3.217

6.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

7.  Screening occupational populations for asymptomatic or early peripheral neuropathy.

Authors:  L Moody; J Arezzo; D Otto
Journal:  J Occup Med       Date:  1986-10

8.  Quantitative vibration perception thresholds in normal and diabetic chinese: influence of age, height and body mass index.

Authors:  Chii-Min Hwu; Hsing-Yi Chang; Jim-Yi Chen; Shu-Li Wang; Low-Tone Ho; Wen-Harn Pan
Journal:  Neuroepidemiology       Date:  2002 Nov-Dec       Impact factor: 3.282

9.  The physical activity scale for the elderly (PASE): evidence for validity.

Authors:  R A Washburn; E McAuley; J Katula; S L Mihalko; R A Boileau
Journal:  J Clin Epidemiol       Date:  1999-07       Impact factor: 6.437

10.  Quantitative vibration perception testing in elderly people: an assessment of variability.

Authors:  F J Thomson; E A Masson; A J Boulton
Journal:  Age Ageing       Date:  1992-05       Impact factor: 10.668

View more
  10 in total

1.  Impairment of color vision in aircraft maintenance workers.

Authors:  Maya Guest; Catherine D'Este; John Attia; May Boggess; Anthony Brown; Meredith Tavener; Richard Gibson; Ian Gardner; Warren Harrex; James Ross
Journal:  Int Arch Occup Environ Health       Date:  2010-11-14       Impact factor: 3.015

2.  Chemotherapy-Induced Neuropathy in Cancer Survivors.

Authors:  Christine Miaskowski; Judy Mastick; Steven M Paul; Kimberly Topp; Betty Smoot; Gary Abrams; Lee-May Chen; Kord M Kober; Yvette P Conley; Margaret Chesney; Kay Bolla; Grace Mausisa; Melissa Mazor; Melisa Wong; Mark Schumacher; Jon D Levine
Journal:  J Pain Symptom Manage       Date:  2017-01-04       Impact factor: 3.612

3.  Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.

Authors:  Melisa L Wong; Bruce A Cooper; Steven M Paul; Gary Abrams; Kimberly Topp; Kord M Kober; Margaret A Chesney; Melissa Mazor; Mark A Schumacher; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2019-02-15       Impact factor: 3.603

4.  Age, gender, and side differences of cutaneous electrical perceptual threshold testing in an able-bodied population.

Authors:  Grace Woon Su Leong; Jenny Lauschke; Susan B Rutowski; Phil M Waite
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

5.  Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.

Authors:  Kord M Kober; Melissa Mazor; Gary Abrams; Adam Olshen; Yvette P Conley; Marilyn Hammer; Mark Schumacher; Margaret Chesney; Betty Smoot; Judy Mastick; Steven M Paul; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2018-08-30       Impact factor: 3.612

6.  Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.

Authors:  Christine Miaskowski; Steven M Paul; Judy Mastick; Mark Schumacher; Yvette P Conley; Betty Smoot; Gary Abrams; Kord M Kober; Steven Cheung; Jennifer Henderson-Sabes; Margaret Chesney; Melissa Mazor; Margaret Wallhagen; Jon D Levine
Journal:  Eur J Oncol Nurs       Date:  2017-11-07       Impact factor: 2.398

Review 7.  Chemobrain: a translational challenge for neurotoxicology.

Authors:  Bernard Weiss
Journal:  Neurotoxicology       Date:  2008-04-09       Impact factor: 4.294

8.  Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.

Authors:  Christine Miaskowski; Judy Mastick; Steven M Paul; Gary Abrams; Steven Cheung; Jennifer Henderson Sabes; Kord M Kober; Mark Schumacher; Yvette P Conley; Kimberly Topp; Betty Smoot; Grace Mausisa; Melissa Mazor; Margaret Wallhagen; Jon D Levine
Journal:  J Cancer Surviv       Date:  2017-11-20       Impact factor: 4.442

9.  Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone.

Authors:  S Goel; G L Goldberg; D Y-S Kuo; F Muggia; J Arezzo; S Mani
Journal:  Ann Oncol       Date:  2008-07-21       Impact factor: 32.976

10.  Examining practice effects in repeated measurements of vibration perception thresholds on finger pulps of healthy individuals - Is it possible to improve your results over a clinically relevant test interval?

Authors:  Linnéa Ekman; Jin Persson Löfgren; Lars B Dahlin
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.